"Prenosis AI Tool Receives FDA Approval for Sepsis Detection"
TL;DR
The FDA has authorized the first AI-driven diagnostic tool for sepsis, developed by Chicago-based company Prenosis, to predict the risk of the condition, which contributes to at least 350,000 deaths annually in the US. The tool, based on an algorithm trained with over 100,000 blood samples and clinical data, categorizes a patient's sepsis risk into four levels. This development comes as federal health agencies prioritize sepsis management, with hospitals increasingly considering the integration of artificial intelligence into patient care despite concerns among some frontline workers.
- FDA approves AI-driven tests for sepsis made by Prenosis The Washington Post
- 1 in 3 Americans who die in hospital had sepsis–and that's just one of the many areas where AI can improve early diagnosis Fortune
- Scientists identify distinct molecular signatures for sepsis diagnosis and prognosis News-Medical.Net
- FDA authorizes Prenosis software as first AI tool that can diagnose sepsis CNBC
- FDA Approves First AI Sepsis Detection Tool, Prenosis Says Forbes
Want the full story? Read the original reporting
Read on The Washington Post